liver and semaglutide Gets FDA Greenlight for MASH Wegovy Treated Severe Liver Disease

Special Population Dosing Considerations Certain populations require modified approaches beyond standard protocols

(FYI: Wegovy is FDA-approved for long-term weight management, while Ozempic is FDA-approved to treat type 2 diabetes but often prescribed off-label for medical weight loss.) My practitioner discussed the possible risks and side effects such as nausea, constipation, abdominal pain, and even pancreatitis, but explained that starting at a low dose of semaglutide would be best to keep side effects at bay and see how my body reacted

Breastfeeding is not recommended with oral semaglutide (Rybelsus brand)

Years of research on the safety and effectiveness of the drugs is required

However, our research sought to address these issues by demonstrating that with proper support, maintaining weight loss after discontinuation is indeed achievable

doi:10.1093/clinchem/hvad022